Technical Analysis for SCNI - Scinai Immunotherapeutics Ltd.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| 20 DMA Resistance | Bearish | 1.73% | |
| MACD Bearish Signal Line Cross | Bearish | 1.73% | |
| Fell Below 20 DMA | Bearish | -3.09% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -3.09% | |
| MACD Bullish Signal Line Cross | Bullish | -3.09% | |
| Inside Day | Range Contraction | -3.09% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -5.18% |
| Alert | Time |
|---|---|
| Gap Up Closed | 2 days ago |
| Reversed from Up | 2 days ago |
| 60 Minute Opening Range Breakdown | 2 days ago |
| Gapped Up (Full) | 2 days ago |
| Rose Above Previous Day's High | 2 days ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2023
Scinai Immunotherapeutics Ltd. is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products primarily for the treatment of autoimmune and infectious diseases. With a state-of-the-art facility for biopharmaceutical product development and manufacturing and highly experienced pharmaceutical industry leadership, Scinai offers end-to-end boutique CDMO services in parallel to developing its own pipeline of diversified and commercially viable products and platforms beginning with an innovative nanosized VHH antibody (NanoAb) pipeline targeting diseases with large unmet medical needs.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Disease Contract Manufacturing Organization Autoimmune And Infectious Diseases
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Disease Contract Manufacturing Organization Autoimmune And Infectious Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.27 |
| 52 Week Low | 0.1 |
| Average Volume | 29,728 |
| 200-Day Moving Average | 0.77 |
| 50-Day Moving Average | 0.49 |
| 20-Day Moving Average | 0.47 |
| 10-Day Moving Average | 0.46 |
| Average True Range | 0.04 |
| RSI (14) | 44.44 |
| ADX | 17.57 |
| +DI | 9.24 |
| -DI | 11.51 |
| Chandelier Exit (Long, 3 ATRs) | 0.42 |
| Chandelier Exit (Short, 3 ATRs) | 0.54 |
| Upper Bollinger Bands | 0.51 |
| Lower Bollinger Band | 0.44 |
| Percent B (%b) | 0.26 |
| BandWidth | 14.67 |
| MACD Line | -0.01 |
| MACD Signal Line | -0.01 |
| MACD Histogram | -0.0006 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.51 | ||||
| Resistance 3 (R3) | 0.51 | 0.50 | 0.50 | ||
| Resistance 2 (R2) | 0.50 | 0.48 | 0.50 | 0.50 | |
| Resistance 1 (R1) | 0.48 | 0.48 | 0.47 | 0.47 | 0.49 |
| Pivot Point | 0.46 | 0.46 | 0.46 | 0.46 | 0.46 |
| Support 1 (S1) | 0.44 | 0.45 | 0.44 | 0.44 | 0.42 |
| Support 2 (S2) | 0.43 | 0.44 | 0.43 | 0.42 | |
| Support 3 (S3) | 0.41 | 0.43 | 0.42 | ||
| Support 4 (S4) | 0.41 |
